Interferons as therapy for viral and neoplastic diseases: From panacea to pariah to paragon

Robert M. Friedman; Sara Contente

doi:10.3390/ph2030206

Interferons as therapy for viral and neoplastic diseases: From panacea to pariah to paragon

Robert M. Friedman^*
, Sara Contente

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.

Original language	English
Pages (from-to)	206-216
Number of pages	11
Journal	Pharmaceuticals
Volume	2
Issue number	3
DOIs	https://doi.org/10.3390/ph2030206
State	Published - Dec 2009

Keywords

Cancer
Clinical applications
Infectious diseases
Interferon
Multiple sclerosis

Access to Document

10.3390/ph2030206

Cite this

@article{c81ec1bb97fe49fe8eb1ddd512669c3f,

title = "Interferons as therapy for viral and neoplastic diseases: From panacea to pariah to paragon",

abstract = "For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.",

keywords = "Cancer, Clinical applications, Infectious diseases, Interferon, Multiple sclerosis",

author = "Friedman, \{Robert M.\} and Sara Contente",

note = "Publisher Copyright: {\textcopyright} 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.",

year = "2009",

month = dec,

doi = "10.3390/ph2030206",

language = "English",

volume = "2",

pages = "206--216",

journal = "Pharmaceuticals",

issn = "1424-8247",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - Interferons as therapy for viral and neoplastic diseases

T2 - From panacea to pariah to paragon

AU - Friedman, Robert M.

AU - Contente, Sara

PY - 2009/12

Y1 - 2009/12

N2 - For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.

AB - For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.

KW - Cancer

KW - Clinical applications

KW - Infectious diseases

KW - Interferon

KW - Multiple sclerosis

UR - https://www.scopus.com/pages/publications/85074822214

U2 - 10.3390/ph2030206

DO - 10.3390/ph2030206

M3 - Review article

AN - SCOPUS:85074822214

SN - 1424-8247

VL - 2

SP - 206

EP - 216

JO - Pharmaceuticals

JF - Pharmaceuticals

IS - 3

ER -

Interferons as therapy for viral and neoplastic diseases: From panacea to pariah to paragon

Abstract

Keywords

Access to Document

Fingerprint

Cite this